Geneva researchers detect 90% of colorectal cancers

Geneva researchers developed a non-invasive method detecting 90% of colorectal cancers using stool samples. This new approach analyzes gut bacteria, offering a promising alternative to uncomfortable and costly colonoscopies for early detection. The method's accuracy is close to colonoscopies and could become a primary screening tool, with potential applications for other diseases.